[Diagnosis of and therapy for hepatocellular carcinoma].

Greten, T F, TF; Malek, N P, NP; Schmidt, S, S; Arends, J, J; Bartenstein, P, P; Bechstein, W, W; Bernatik, T, T; Bitzer, M, M; Chavan, A, A; Dollinger, M, M; Domagk, D, D; Drognitz, O, O; Düx, M, M; Farkas, S, S; Folprecht, G, G; Galle, P, P; Geißler, M, M; Gerken, G, G; Habermehl, D, D; Helmberger, T, T; Herfarth, K, K; Hoffmann, R T, RT; Holtmann, M, M; Huppert, P, P; Jakobs, T, T; Keller, M, M; Klempnauer, J, J; Kolligs, F, F; Körber, J, J; Lang, H, H; Lehner, F, F; Lordick, F, F; Lubienski, A, A; Manns, M P, MP; Mahnken, A, A; Möhler, M, M; Mönch, C, C; Neuhaus, P, P; Niederau, C, C; Ocker, M, M; Otto, G, G; Pereira, P, P; Pott, G, G; Riemer, J, J; Ringe, K, K; Ritterbusch, U, U; Rummeny, E, E; Schirmacher, P, P; Schlitt, H J, HJ; Schlottmann, K, K; Schmitz, V, V; Schuler, A, A; Schulze-Bergkamen, H, H; von Schweinitz, D, D; Seehofer, D, D; Sitter, H, H; Straßburg, C P, CP; Stroszczynski, C, C; Strobel, D, D; Tannapfel, A, A; Trojan, J, J; van Thiel, I, I; Vogel, A, A; Wacker, F, F; Wedemeyer, H, H; Wege, H, H; Weinmann, A, A; Wittekind, C, C; Wörmann, B, B; Zech, C J, CJ     «

Greten, T F, TF; Malek, N P, NP; Schmidt, S, S; Arends, J, J; Bartenstein, P, P; Bechstein, W, W; Bernatik, T, T; Bitzer, M, M; Chavan, A, A; Dollinger, M, M; Domagk, D, D; Drognitz, O, O; Düx, M, M; Farkas, S, S; Folprecht, G, G; Galle, P, P; Geißler, M, M; Gerken, G, G; Habermehl, D, D; Helmberger, T, T; Herfarth, K, K; Hoffmann, R T, RT; Holtmann, M, M; Huppert, P, P; Jakobs, T, T; Keller, M, M; Klempnauer, J, J; Kolligs, F, F; Körber, J, J; Lang, H, H; Lehner, F, F; Lordick, F, F; Lubienski,...     »

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life.     «

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limite...     »